ICN2 Plasmonic Biosensor for COVID and other conditions [02-03-2022]
An innovative nano-biosensor assay for fast, quantitative and accurate COVID-19 serology, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the NanoBiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2, Barcelona, Spain). The sensor combines the high reliability of specialised laboratory analysis with the short turnaround times and simple operability of rapid self-tests.
Related News
Nano-sensor detects pesticides on fruit in minutes [07-06-2022]
Nanosensors & Nanodevices
Protein nanoparticle vaccine shows potential for broader, safe SARS-CoV-2 vaccines [26-05-2022]
Nanobiotechnology, Nanomedicine
Researchers take a step toward creating an axle-rotor nanomachine [21-04-2022]
Nanobiotechnology, Nanotechnologies
Extremely sensitive nano-sensors can detect trace amounts of molecules [19/04/2022]
Nanosensors & Nanodevices
INBRAIN Neuroelectronics signs an agreement to develop neurotechnology patented by six public research institutions [15-03-2022]
Nanobiotechnology, Nanomedicine, Graphene

© Phantoms Foundation 2022